Researchmoz added Most up-to-date research on "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt" to its huge collection of research reports.
Latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Egypt. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476972
In 2016, Egypt population was approximately at 90.2 million. Egypt has the largest pharmaceutical manufacturing base in the Middle East and North Africa (MENA) region, representing around 30% of the regional market. Its pharmaceutical market was worth $2.31 billion in 2009 and an estimated $5.43 billion in 2016, having grown at a Compound Annual Growth Rate (CAGR) of 14.1%. The market is estimated to reach $10.50 billion in 2021. The Egyptian medical device market was valued at $0.70 billion in 2009 and is one of the growing industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $0.95 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $1.23 billion in 2021. The segments expected to experience high growth are cardiovascular devices, orthopedic device, drug delivery devices, in vitro diagnostics and healthcare IT.
These positive trends can primarily be attributed to -
- Government initiatives to develop and modernize government hospitals and therapeutic centres in various parts of the country
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (GSK, Novartis, Sanofi, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO))
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Egyptian healthcare market
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-egypt-report.html/toc
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Egyptian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Egyptian healthcare market
Latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Egypt. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476972
In 2016, Egypt population was approximately at 90.2 million. Egypt has the largest pharmaceutical manufacturing base in the Middle East and North Africa (MENA) region, representing around 30% of the regional market. Its pharmaceutical market was worth $2.31 billion in 2009 and an estimated $5.43 billion in 2016, having grown at a Compound Annual Growth Rate (CAGR) of 14.1%. The market is estimated to reach $10.50 billion in 2021. The Egyptian medical device market was valued at $0.70 billion in 2009 and is one of the growing industries in the healthcare sector, due to the aging population and consequent increase in demand for healthcare products and services. It grew to $0.95 billion at a CAGR of 4.2% between 2009 and 2016 and is forecast to reach $1.23 billion in 2021. The segments expected to experience high growth are cardiovascular devices, orthopedic device, drug delivery devices, in vitro diagnostics and healthcare IT.
These positive trends can primarily be attributed to -
- Government initiatives to develop and modernize government hospitals and therapeutic centres in various parts of the country
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (GSK, Novartis, Sanofi, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO))
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Egyptian healthcare market
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-egypt-report.html/toc
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Egyptian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Egyptian healthcare market
No comments:
Post a Comment